Carditis at the interface between GERD and Helicobacter pylori infection

Digestive Diseases

Volumn 22, Issue 2, 2004, Pages 120-125

  Peitz, U ^a   Vieth, M ^a   Malfertheiner, P ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Carditis; Gastroesophageal reflux disease; Helicobacter pylori; Intestinal metaplasia

Indexed keywords

ACCURACY; BACTERIAL INFECTION; CARDIA; CARDITIS; CLASSIFICATION; DISEASE ASSOCIATION; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; INCIDENCE; INFLAMMATION; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; METAPLASIA; PH; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STOMACH FUNDUS; SYMPTOM; TISSUE SECTION;

CARDIA; GASTRIC MUCOSA; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 4644292991     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080310     Document Type: Review

References (56)

1. Lembo T, Ippoliti AF, Ramers C, Weinstein WM: Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study. Gut 1999;45:484-488.
2. Bowrey DJ, Clark GW, Williams GT: Patterns of gastritis in patients with gastro-oesophageal reflux disease. Gut 1999;45:798-803.
3. Chandrasoma PT, Der R, Dalton P, Kobayashi G, Ma Y, Peters J, et al: Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol 2001;25:1188-1193.
4. Csendes A, Smok G, Burdiles P, Sagastume H, Rojas J, Puente G, et al: 'Carditis': An objective histological marker for pathologic gastroesophageal reflux disease. Dis Esophagus 1998;11:101-105.
5. Der R, Tsao-Wei DD, Demeester T, Peters J, Groshen S, Lord RV, et al: Carditis: A manifestation of gastroesophageal reflux disease. Am J Surg Pathol 2001;25:245-252.
6. el Zimaity HM, Verghese VJ, Ramchatesingh J, Graham DY: The gastric cardia in gastro-oesophageal disease. J Clin Pathol 2000;53:619-625.
7. Goldstein NS, Karim R: Gastric cardia inflammation and intestinal metaplasia: associations with reflux esophagitis and Helicobacter pylori. Mod Pathol 1999;12:1017-1024.
8. Gulmann C, Rathore O, Grace A, Hegarty H, O'Grady A, Leader M, et al: 'Cardiac-type' (mucinous) mucosa and carditis are both associated with Helicobacter pylori-related gastritis. Eur J Gastroenterol Hepatol 2004;16(1):69-74.
9. Hackelsberger A, Gunther T, Schultze V, Manes G, Dominguez-Munoz JE, Roessner A, et al: Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998;43:17-21.
10. Law S, Lam KY, Chu KM, Wong J: Specialized intestinal metaplasia and carditis at the gastroesophageal junction in Chinese patients undergoing endoscopy. Am J Gastroenterol 2002;97:1924-1929.
11. Oberg S, Peters JH, DeMeester TR, Chandrasoma P, Hagen JA, Ireland AP, et al: Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997;226:522-530.
12. Oksanen A, Sipponen P, Karttunen R, Rautelin H: Inflammation and intestinal metaplasia at the squamocolumnar junction in young patients with or without Helicobacter pylori infection. Gut 2003;52:194-198.
13. Voutilainen M, Farkkila M, Mecklin JP, Juhola M, Sipponen P: Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group. Am J Gastroenterol 1999;94:3175-3180.
14. Zentilin P, Mastracci L, Dulbecco P, Gambaro C, Bilardi C, Ceppa P, et al: Carditis in patients with gastro-oesophageal reflux disease: results of a controlled study based on both endoscopy and 24-h oesophageal pH monitoring. Aliment Pharmacol Ther 2004;19:1285-1292.
15. Devesa SS, Blot WJ, Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-2053.
16. Falk GW: Barrett's esophagus. Gastroenterology 2002;122(6):1569-1591.
17. Schistosomes, Liver Flukes and Helicobacter pylori: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, 7-14 June, 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
18. Meining A, Bayerdorffer E, Muller P, Miehlke S, Lehn N, Holzel D, et al: Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch 1998;432(4):311-314.
19. Owen DA: Stomach; in Sternberg SS (ed): Histology for Pathologists. Philadelphia, Lippincott-Raven, 1992, pp 533-545.
20. Redel CA: Anatomy, histology, embryology, and developmental anomalies of the stomach and duodenum; in Feldman M, Friedman LS, Sleisinger MH (eds): Sleisenger & Fordtran's Gastrointestinal and Liver Disease, ed 7. Philadelphia, Saunders, 2003, pp 675-690.
21. Hayward J: The lower end of the oesophagus. Thorax 1961;16:36-41.
22. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK: The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-480.
23. Kilgore SP, Ormsby AH, Gramlich TL, Rice TW, Richter JE, Falk GW, et al: The gastric cardia: Fact or fiction? Am J Gastroenterol 2000;95:921-924.
24. Derdoy JJ, Bergwerk A, Cohen H, Kline M, Monforte HL, Thomas DW: The gastric cardia: To be or not to be? Am J Surg Pathol 2003;27:499-504.
25. De Hertogh G, Van Eyken P, Ectors N, Tack J, Geboes K: On the existence and location of cardiac mucosa: An autopsy study in embryos, fetuses, and infants. Gut 2003;52:791-796.
26. Oberg S, Johansson J, Wenner J, Walther B: Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg 2002;235:338-345.
27. O'Riordan JM, Tucker ON, Byrne PJ, McDonald GS, Ravi N, Keeling PW, et al: Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomy. Am J Gastroenterol 2004;99:205-211.
28. Peitz U, Vieth M, Pross M, Leodolter A, Malfertheiner P: Cardia-type metaplasia arising in the remnant esophagus after cardia resection. Gastrointest Endosc 2004;59:810-817.
29. Peitz U, Vieth M, Kahl S, Roessner A, Malfertheiner P: The magnified endoscopic view of cardia-type mucosa. Z Gastroenterol 2004;42:371-377.
30. Chandrasoma PT, Der R, Ma Y, Peters J, Demeester T: Histologic classification of patients based on mapping biopsies of the gastroesophageal junction. Am J Surg Pathol 2003;27:929-936.
31. Glickman JN, Fox V, Antonioli DA, Wang HH, Odze RD: Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol 2002;26:1032-1039.
32. Spechler SJ: The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 1999;117:218-228.
33. Morini S, Zullo A, Hassan C, Lorenzetti R, Stella F, Martini MT: Gastric cardia inflammation: Role of Helicobacter pylori infection and symptoms of gastroesophageal reflux disease. Am J Gastroenterol 2001;96:2337-2340.
34. Pieramico O, Zanetti MV: Relationship between intestinal metaplasia of the gastrooesophageal junction, Helicobacter pylori infection and gastro-oesophageal reflux disease: A prospective study. Dig Liver Dis 2000;32:567-572.
35. Wolf C, Seldenrijk CA, Timmer R, Breumelhof R, Smout AJ: Does carditis have two different etiologies? Dig Dis Sci 2001;46:2424-2432.
36. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston, 1994. Am J Surg Pathol 1996;20:1161-1181.
37. Genta RM, Huberman RM, Graham DY: The gastric cardia in Helicobacter pylori infection. Hum Pathol 1994;25:915-919.
38. Hackelsberger A, Gunther T, Schultze V, Labenz J, Roessner A, Malfertheiner P: Prevalence and pattern of Helicobacter pylori gastritis in the gastric cardia. Am J Gastroenterol 1997;92:2220-2224.
39. Goldblum JR, Richter JE, Vaezi M, Falk GW, Rice TW, Peek RM: Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Am J Gastroenterol 2002;97:302-311.
40. Ayhan S, Demir MA, Kandiloglu AR, Saruc M, Kucukmetin N: Features of chronic inflammation at the gastric cardia and the relationship with Helicobacter pylori infection and oesophagitis. Acta Gastroenterol Belg 2003;66:144-149.
41. Chen YY, Antonioli DA, Spechler SJ, Zeroogian JM, Goyal RK, Wang HH: Gastroesophageal reflux disease versus Helicobacter pylori infection as the cause of gastric carditis. Mod Pathol 1998;11:950-956.
42. McNamara D, Buckley M, Crotty P, Hall W, O'Sullivan M, O'Morain C: Carditis: All Helicobacter pylori or is there a role for gastrooesophageal reflux? Scand J Gastroenterol 2002;37:772-777.
43. Goldstein NS: Gastric cardia intestinal metaplasia: Biopsy follow-up of 85 patients. Mod Pathol 2000;13:1072-1079.
44. Borrelli O, Hassall E, D'Armiento F, Bosco S, Mancini V, Di Nardo G et al: Inflammation of the gastric cardia in children with symptoms of acid peptic disease. J Pediatr 2003;143:520-524.
45. Fletcher J, Wirz A, Young J, Vallance R, McColl KE: Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001;121:775-783.
46. Sharma P, Topalovski M, Mayo MS, Sampliner RE, Weston AP: Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia. Am J Gastroenterol 2000;95:3107-3111.
47. Goldblum JR: Inflammation and intestinal metaplasia of the gastric cardia: Helicobacter pylori, gastroesophageal reflux disease, or both. Dig Dis 2000;18:14-19.
48. Bowrey DJ, Williams GT, Carey PD, Clark GW: Inflammation at the cardio-oesophageal junction: Relationship to acid and bile exposure. Eur J Gastroenterol Hepatol 2003;15:49-54.
49. Dixon MF, Mapstone NP, Neville PM, Moayyedi P, Axon AT: Bile reflux gastritis and intestinal metaplasia at the cardia. Gut 2002;51:351-355.
50. Carton E, Caldwell MT, McDonald G, Rama D, Tanner WA, Reynolds JV: Specialized intestinal metaplasia in patients with gastrooesophageal reflux disease. Br J Surg 2000;87:116-121.
51. El Serag HB, Sonnenberg A, Jamal MM, Kunkel D, Crooks L, Feddersen RM: Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol 1999;94:622-627.
52. Nakamura M, Kawano T, Endo M, Iwai T: Intestinal metaplasia at the esophagogastric junction in Japanese patients without clinical Barrett's esophagus. Am J Gastroenterol 1999;94:3145-3149.
53. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK: Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data. Gastroenterology 1999;116:277-285.
54. Ormsby AH, Kilgore SP, Goldblum JR, Richter JE, Rice TW, Gramlich TL: The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: Implications for patient treatment and preventive strategies in Barrett's esophagus. Mod Pathol 2000;13:614-620.
55. Voutilainen M, Farkkila M, Juhola M, Mecklin JP, Sipponen P: Complete and incomplete intestinal metaplasia at the oesophagogastric junction: Prevalences and associations with endoscopic erosive oesophagitis and gastritis. Gut 1999;45:644-648.
56. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK: Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-1536.